/
GBCS
$5.21-$0.02 (-0.41%)prev close
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
52-week range
$1.50 – $5.60
90% from low
Exchange
OTC Link
CS
Borrow rate
0.25%
Easy to borrow
Price (6 mo)
Loading chart…
Change$-1.79
Valuation
Financials
Loading chart…
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $3.6M | $6.9M | $20.9M | $29.3M | $40.6M | $36.8M | $39.5M | $41.4M |
| Cost of revenue | $791.0K | $2.8M | $13.4M | $21.5M | $29.9M | $31.4M | $30.4M | $34.7M |
| Gross profit | $2.8M | $4.2M | $7.5M | $7.8M | $10.7M | $5.4M | $9.1M | $6.7M |
| Gross margin | 78.2% | 60.2% | 36.0% | 26.7% | 26.5% | 14.7% | 23.1% | 16.2% |
| R&D | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Operating income | $340.0K | $1.3M | $3.4M | −$729.0K | −$287.0K | −$9.0M | −$2.7M | −$1.6M |
| EBITDA | $1.5M | $2.5M | $5.0M | $1.0M | $1.5M | −$7.3M | $1.2M | $2.2M |
| Net income | −$2.0M | −$862.0K | $3.0M | −$2.3M | −$2.4M | −$4.0M | −$2.4M | −$1.0M |
| Net margin | -55.0% | -12.4% | 14.1% | -7.7% | -5.9% | -10.8% | -6.1% | -2.5% |
| EPS (diluted) | -0.74 | -0.30 | 0.30 | -0.82 | -0.79 | -1.31 | -0.80 | -0.34 |
Annual figures · source: Financial Modeling Prep
Analyst estimates (consensus)
| Year | Est. revenue | Est. EPS | EPS range | # Analysts |
|---|---|---|---|---|
| 2026 | $28M | $0.06 | $0.06–$0.06 | 1 |
| 2027 | $35M | $1.68 | $1.68–$1.68 | 1 |
| 2028 | $38M | $2.39 | $2.39–$2.39 | 1 |
Forward consensus · source: Financial Modeling Prep
DCF fair valuemodel estimate
Intrinsic value
$23.51
Price
$5.21
Implied upside
+351%
Peer comparison
SELECTIS HEALTH INC
SELECTIS HEALTH INC
Held by traders on TradeandTell
No one on the platform currently holds GBCS.
Super investors & insiders
Institutions holding (13F)
No tracked institution reports a position in GBCS as of their last filing.
Insider activity (SEC Form 4)
Stock splits
| Execution date | Ratio |
|---|---|
| 2021-09-22 | 1-for-10reverse |
Recent trades on TradeandTell
No one on the platform has traded GBCS yet.